Automation is transforming clinical supply operations, but human expertise still drives outcomes. Success comes from combining smart systems with experienced judgment.
- Engaging Commercial Supply Chain Professionals Early In Clinical Supply Selection
- Managing Global Programs Across Multiple Stakeholders
- Managing Inbound Supply Risk With R3M In Clinical Supply Chains
- Export Control Risks Hidden In Clinical Supply Workflows
- The Post-American Supply Chain: Navigating The New Multipolar Clinical Landscape
- Building Resilient Clinical Supply Chains In An Era Of Global Disruption
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- Forecast Vs. Actual: Why Protocol Design Breaks Clinical Supply Plans
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials
Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.
-
How Modern Software Architecture Is Revolutionizing IRT Solutions
Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.
-
Finding The Optimal IRT/RTSM Design For Your Clinical Trial
Determine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.
-
3 Study Areas Where Your IRT Vendor Should Do More
Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
-
Critical Requirements In Sourcing Comparator Drugs
Sourcing comparator drugs has become complex in the clinical supply chain. As a result, clinical trial sponsors and pharma companies are eager to identify opportunities to overcome these challenges.
-
Precision and Compliance in Pharmaceutical Packaging
Reliable, compliant packaging preserves product integrity, supports regulatory readiness, and lowers risk. Careful components and controlled processes keep complex therapies protected.
-
IRT: A New Approach To Meeting The Needs Of Early Phase Trials
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
Writing Effective Clinical Regulatory Documents For Therapy Trials
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
How Intelligent IRT Is Redefining Clinical Supply Chains
Traditional clinical supply chains can't keep up. Learn how smart IRT platforms use real-time data to prevent shortages, cut waste, and keep trials running smoothly.
-
Lifecycle Planning For Containment And Delivery Of Biologics Drug Products
Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.